Outcome | Intervention | Control | Difference (p) |
---|---|---|---|
FPG (mg/dl) | |||
Baseline | 89.6 (11.2) | 91.9 (10.7) | 2.3 (0.7) |
12 months | 87.3 (4.9) | 123.2 (36.8) | 28.4 (< 0.01) |
Difference (p) | 2.3 (0.0) | 31.3 (0.1) | |
2-hour post-OGTT plasma glucose (mg/dl) | |||
Baseline | 109.2 (17.4) | 113.4 (15.9) | 4.2 (0.7) |
12 months | 106.5 (4.5) | 156.1 (37.9) | 50.5 (< 0.01) |
Difference (p) | 2.6 (< 0.01) | 42.7 (< 0.01) | |
HbA1c (%) | |||
Baseline | 6.2 (1.6) | 6.8 (2.2) | 0.5 (0.07) |
12 months | 5.3 (0.4) | 6.8 (1.9) | 1.5 (< 0.01) |
Difference | 0.9 (0.0) | 0.0 (0.8) | |
HOMA-ir | |||
Baseline | 1.9 (1.9) | 2.5 (2.9) | 0.6 (0.6) |
12 months | 0.9 (0.4) | 2.3 (1.3) | 0.2 (< 0.01) |
Difference | 1 (< 0.01) | 0.6 (0.6) |